v3.25.1
Financial Instruments (Tables)
 12 Months Ended
Dec. 31, 2024
Financial Instruments [Abstract]  
Schedule of Financial Instruments

The classification of financial instruments is presented in the following table. There are no financial instruments classified in categories other than those reported:

 

   Classification  Level  12/31/2024   12/31/2023 
Financial liabilities:                
Derivative warrants (note 17)  FVTPL  Level 1   7,663    4,464 
Contingent consideration on acquisitions (note 5)  FVTPL  Level 3   
-
    144,526 
Exposure premium - debentures (note 15)  FVTPL  Level 3   2,940    1,835 
Deferred consideration on acquisitions (note 5)  Amortized cost      277,183    87,551 
Loans and financing (note 13)  Amortized cost      2,887    5,289 
Debentures (note 15)  Amortized cost      40,740    51,197 
Related parties (note 9)  Amortized cost      1,078    9,867 
Schedule of Measurement and Reconciliation of Financial Liabilities

Measurement and reconciliation of level 3 financial liabilities

 

Balance at January 1, 2022   290,944 
Additions   35,846 
Payments   (9,898)
Derecognition of Mercos deferred and contingent consideration   (62,745)
Transfer of contingent consideration to Amortized Cost   (97,725)
Balance at December 31, 2022   156,422 
Additions   29,282 
Transfer to equity (converted in shares)   (35,410)
Write off in the P&L   (3,933)
Balance at December 31, 2023   146,361 
Additions   50,279 
Payments   (7,800)
Transfer of contingent consideration to Amortized Cost   (185,900)
Balance at December 31, 2024   2,940 
Schedule of Significant Unobservable Inputs Used in the Fair Value Measurement For the years ended December 31, 2024 and 2023, the methods, assumptions, and significant unobservable inputs used in the fair value measurement categorized within level 3 of the fair value hierarchy were the following:
    Valuation technique   Significant unobservable input   Relationship of inputs to fair value
Contingent consideration on acquisitions   Income approach- Revenue multiples   Weighted average cost of capital, projected future revenues   The higher the weighted average cost of capital, the lower the fair value. The higher the revenue projections, the higher the fair value.
             
Exposure premium   Income approach- Monte carlo   Future cash flow projections, discount rate, future interest rates, market volatility, probability of occurrence of future liquidity events   The higher the discount rate, the lower the fair value. The higher the probability of a liquidity event, the higher the fair value.
             
Subscription rights   Income approach- Monte carlo   Future cash flow projections, discount rate, future interest rates, market volatility, probability of occurrence of future liquidity events   The higher the discount rate, the lower the fair value. The higher the probability of a liquidity event, the higher the fair value.
Schedule of Liquidity Risk
   12/31/2024 
   Less than
1 year		   1 to 3 years   Total Liabilities 
Accounts payable to suppliers   61,284    
-
    61,284 
Other liabilities   775    
-
    775 
Loans and financing   2,512    375    2,887 
Debentures(i)     40,740    
-
    40,740 
Deferred and contingent consideration   277,183    
-
    277,183 
Lease liabilities   773    1,118    1,891 
Related parties   1,078    
-
    1,078 
Total   384,345    1,493    385,838 

 

   12/31/2023 
   Less than
1 year		   1 to 3 years   Total Liabilities 
Accounts payable to suppliers   47,133    
-
    47,133 
Other liabilities   852    
-
    852 
Loans and financing   4,960    329    5,289 
Debentures(i)     51,197    
-
    51,197 
Deferred and contingent consideration   227,077    5,000    232,077 
Lease liabilities   742    777    1,519 
Related parties   9,867    
-
    9,867 
Total   341,828    6,106    347,934 

 

(i) The Company was not in compliance with the related financial covenants under the debentures on December 31, 2024, and 2023, and the amounts owed under the debentures are classified as current. Refer to Note 15 for details relating to these covenants and waiver obtained by the Company. Contractual principal payments are due quarterly beginning in May 2023 with final maturity in May 2026, as follows:
Schedule of Contractual Principal Payments Due with Final Maturity Contractual principal payments are due quarterly beginning in May 2023 with final maturity in May 2026, as follows:
    Less than
1 year		     1 to 3 years     3 to 5 years     Total Liabilities  
Debentures     -       40,740       -       40,740  
Schedule of Estimating an Increase or Decrease Profit or Loss

Estimating an increase or a decrease of (i) projected forecast, (ii) 25% or (iii) 50% in interest rate, would increase or decrease profit or loss as follows:

 

   Scenario I   Scenario II   Scenario III 
   (Probable) (ii)   +/-25%   +/-50% 
Potential net effect on profit or loss   (250)   (1,149)   (2,047)

 

         Exposure     Scenario I     Scenario II     Scenario III 
Indicators  12/31/2024   Spot rates (i)   (Probable) (ii)   +/-25%   +/-50% 
Assets        11.87%   12.76%   15.95%   19.13%
Short-term investments—101% of CDI   13,238         118    540    962 
Exposure to CDI—Assets   13,238         118    540    962 
Liability        11.75%   12.63%   15.79%   18.95%
Related parties—100% of CDI   (1,078)        (9)   (44)   (78)
Debentures—100% of CDI   (40,740)        (359)   (1,645)   (2,931)
Exposure to CDI—Liabilities   (41,818)        (368)   (1,688)   (3,009)
Net exposure   (28,580)        (250)   (1,149)   (2,047)

 

(i) Based on spot rate, as of the date of this financial statements, as published by the Central Bank of Brazil.

 

(ii) Based on the projected forecast, as of December 31, 2024, as published by the Central Bank of Brazil.